News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
232,030 Results
Type
Article (5091)
Company Profile (24)
Press Release (226915)
Multimedia
Podcasts (2)
Webinars (4)
Section
Business (82255)
Career Advice (463)
Deals (15055)
Drug Delivery (8)
Drug Development (19076)
Employer Resources (30)
FDA (3683)
Job Trends (3909)
News (120191)
Policy (7517)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (293)
Accelerated approval (6)
Adcomms (4)
Allergies (14)
Alliances (14809)
ALS (38)
Alzheimer's disease (294)
Antibody-drug conjugate (ADC) (40)
Approvals (3783)
Artificial intelligence (80)
Autoimmune disease (27)
Automation (5)
Bankruptcy (97)
Best Places to Work (2865)
Biosimilars (32)
Biotechnology (23)
Bladder cancer (34)
Brain cancer (7)
Breast cancer (101)
Cancer (886)
Cardiovascular disease (61)
Career advice (395)
Career pathing (3)
CAR-T (64)
CDC (2)
Cell therapy (166)
Cervical cancer (5)
Clinical research (16684)
Collaboration (353)
Compensation (371)
Complete response letters (8)
COVID-19 (312)
CRISPR (13)
C-suite (339)
Cystic fibrosis (28)
Data (1325)
Denatured (1)
Depression (21)
Diabetes (78)
Diagnostics (2117)
Digital health (7)
Diversity (1)
Diversity, equity & inclusion (13)
Drug discovery (31)
Drug pricing (15)
Drug shortages (2)
Duchenne muscular dystrophy (35)
Earnings (42741)
Editorial (5)
Employer branding (6)
Employer resources (32)
Events (39138)
Executive appointments (424)
FDA (4421)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (340)
Gene editing (24)
Generative AI (5)
Gene therapy (102)
GLP-1 (144)
Government (424)
Guidances (197)
Healthcare (5051)
HIV (10)
Huntington's disease (5)
IgA nephropathy (11)
Immunology and inflammation (39)
Immuno-oncology (7)
Indications (16)
Infectious disease (338)
Inflammatory bowel disease (36)
Inflation Reduction Act (3)
Influenza (6)
Intellectual property (32)
Interviews (53)
IPO (7881)
IRA (3)
Job creations (1122)
Job search strategy (361)
JPM (4)
Kidney cancer (10)
Labor market (10)
Layoffs (106)
Leadership (5)
Legal (2338)
Liver cancer (21)
Longevity (2)
Lung cancer (92)
Lymphoma (70)
Machine learning (3)
Management (10)
Manufacturing (139)
MASH (50)
Medical device (3922)
Medtech (3932)
Mergers & acquisitions (7579)
Metabolic disorders (214)
Multiple sclerosis (18)
NASH (6)
Neurodegenerative disease (54)
Neuropsychiatric disorders (12)
Neuroscience (539)
NextGen: Class of 2026 (1674)
Non-profit (731)
Now hiring (5)
Obesity (84)
Opinion (32)
Ovarian cancer (26)
Pain (26)
Pancreatic cancer (38)
Parkinson's disease (50)
Partnered (6)
Patents (51)
Patient recruitment (96)
Peanut (6)
People (25221)
Pharmaceutical (7)
Pharmacy benefit managers (3)
Phase 1 (4995)
Phase 2 (7227)
Phase 3 (5789)
Pipeline (1962)
Policy (17)
Postmarket research (625)
Preclinical (1947)
Press Release (66)
Prostate cancer (57)
Psychedelics (3)
Radiopharmaceuticals (109)
Rare diseases (179)
Real estate (1887)
Recruiting (8)
Regulatory (5538)
Reports (17)
Research institute (308)
Resumes & cover letters (69)
Rett syndrome (19)
RNA editing (1)
RSV (2)
Schizophrenia (49)
Series A (53)
Series B (54)
Sickle cell disease (10)
Special edition (2)
Spinal muscular atrophy (33)
Sponsored (5)
Startups (1017)
Stomach cancer (1)
Supply chain (13)
Tariffs (7)
The Weekly (1)
Vaccines (80)
Venture capital (9)
Weight loss (29)
Women's health (6)
Date
Today (8)
Last 7 days (146)
Last 30 days (647)
Last 365 days (8910)
2026 (785)
2025 (9036)
2024 (11032)
2023 (13194)
2022 (18668)
2021 (19684)
2020 (18242)
2019 (13208)
2018 (10206)
2017 (10001)
2016 (9156)
2015 (12119)
2014 (9587)
2013 (7707)
2012 (8329)
2011 (8796)
2010 (8634)
Location
Africa (186)
Alabama (19)
Alaska (2)
Arizona (74)
Arkansas (1)
Asia (11784)
Australia (1690)
California (3541)
Canada (1138)
China (167)
Colorado (143)
Connecticut (162)
Delaware (70)
Europe (25487)
Florida (541)
Georgia (67)
Idaho (24)
Illinois (161)
India (14)
Indiana (106)
Iowa (9)
Japan (164)
Kansas (36)
Kentucky (17)
Louisiana (8)
Maine (51)
Maryland (352)
Massachusetts (2803)
Michigan (104)
Minnesota (201)
Mississippi (1)
Missouri (31)
Montana (17)
Nebraska (12)
Nevada (46)
New Hampshire (16)
New Jersey (1018)
New Mexico (5)
New York (814)
North Carolina (479)
North Dakota (4)
Northern California (1854)
Ohio (116)
Oklahoma (5)
Oregon (6)
Pennsylvania (597)
Puerto Rico (1)
Rhode Island (19)
South America (279)
South Carolina (17)
Southern California (1304)
Tennessee (62)
Texas (480)
United States (12330)
Utah (111)
Virginia (84)
Washington D.C. (17)
Washington State (297)
West Virginia (2)
Wisconsin (57)
Wyoming (1)
232,030 Results for "centene corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
CENTENE CORPORATION REPORTS THIRD QUARTER 2025 RESULTS
October 29, 2025
·
32 min read
Press Releases
CENTENE CORPORATION REPORTS SECOND QUARTER 2025 RESULTS
July 25, 2025
·
30 min read
Press Releases
CENTENE CORPORATION REPORTS FIRST QUARTER 2025 RESULTS
April 25, 2025
·
31 min read
Business
Centene Corporation Reports First Quarter 2024 Results
Centene Corporation announced its financial results for the first quarter ended March 31, 2024.
April 26, 2024
·
30 min read
Business
Centene Corporation Reports 2023 Results
Centene Corporation announced its financial results for the fourth quarter and year ended December 31, 2023.
February 6, 2024
·
38 min read
Press Releases
CENTENE CORPORATION ANNOUNCES 2025 GUIDANCE
December 13, 2024
·
12 min read
Press Releases
CENTENE CORPORATION TO HOST INVESTOR DAY ON DECEMBER 12, 2024
December 3, 2024
·
1 min read
Business
Centene Corporation Announces 2024 Guidance
Centene Corporation will host its investor day to outline its 2024 financial guidance as well as provide updates on its long-term strategic plan, designed to deliver long-term shareholder value.
December 12, 2023
·
12 min read
Press Releases
CENTENE CORPORATION TO HOST VIRTUAL INVESTOR DAY ON DECEMBER 12, 2024
December 6, 2024
·
2 min read
BioMidwest
CENTENE CORPORATION TO HOST INVESTOR DAY ON DECEMBER 12, 2023
Centene Corporation (NYSE: CNC) (“the Company”) today announced that it will host an investor day on Tuesday, December 12, 2023.
December 4, 2023
·
1 min read
1 of 23,203
Next
